David Kerstein

David Kerstein, M.D. is Chief Medical Officer at Theseus Pharmaceuticals. David is a physician and an experienced oncology clinical research and development leader. Prior to joining Theseus, David served as Chief Medical Officer and Senior Vice President at Anchiano Therapeutics, a clinical-stage oncology company. He previously served as Senior Medical Director of Oncology Clinical Research at Takeda Pharmaceuticals, where he was the lung cancer clinical portfolio strategy lead and global clinical lead for brigatinib. Prior, David was Senior Medical Director of Clinical Research at ARIAD Pharmaceuticals, where he led the clinical development program, and New Drug Application and Marketing Authorization submissions for brigatinib. Previously, at Boston Biomedical, he was Director of Clinical Development and Regulatory Affairs. David received his M.D. from Tufts University School of Medicine and his B.S. in Biology from Tufts University.